The Cholesterol Myth

Why Your Brain and Body Need More Than You Think

Navigating the Statin Industrial Complex and the War on Dietary Health

In today's cardiovascular health landscape, cholesterol has become the ultimate villain. We are conditioned to view lab results through a strict binary lens: lower is better, and anything above 200 mg/dL is a ticking time bomb.

However, this clinical obsession ignores a fundamental biological reality. Cholesterol is not a poison; it is an essential nutrient. In our aggressive pursuit to suppress these levels globally, with tens of millions of people currently taking statin medications worldwide, we may be inadvertently sabotaging our most critical organ: the brain.

The Brain's Vital Requirement: The human brain is an anatomical marvel, containing about 20% of the body's total cholesterol despite making up only about 2% of its weight. It is not merely a bystander in systemic metabolism; the brain requires cholesterol for structural integrity, synaptic plasticity, and effective neurotransmission.

Note: As an Amazon Associate, I earn from qualifying purchases. This helps support this blog. Please see my favorite product at the bottom of this post.

Because the blood-brain barrier effectively isolates the central nervous system from circulating peripheral lipids, the brain must synthesize its own supply.

Yet, the health of the body's peripheral cholesterol remains vital for overall cellular function. When we force systemic cholesterol to plummet, particularly below 95 mg/dL, we risk impairing fundamental biological processes, including cell membrane integrity and immune function. Research indicates that excessively low cholesterol is associated with increased all-cause mortality, including higher risks of stroke and certain cancers, suggesting that our clinical "target" levels may be dangerously misguided.

The Statin Conundrum: A Costly Intervention

The pharmaceutical push to lower cholesterol is a multi-billion-dollar economic engine. Statins are a cornerstone of this corporate empire, with global sales that have historically reached tens of billions of dollars annually. Although they are heavily marketed as universal lifesavers, their rapid, widespread adoption has coincided with an alarming rise in cognitive, neurological, and neuromuscular complaints.

As we age, lipid metabolism naturally shifts. Yet statins actively block the mevalonate pathway, depriving the body of compounds essential for cellular maintenance (and potentially disrupting the delicate balance the brain needs).

Allow that to sink in for a moment.

Given this biological necessity, it is worth questioning whether the introduction and aggressive marketing of multiple major statins by pharmaceutical giants correlate with the documented spike in cognitive decline among aging populations.

Statins are well-documented to cause significant side effects. Neuromuscular adverse events, ranging from muscle weakness and myalgia to severe conditions like rhabdomyolysis, are well-established. Beyond the muscles, many patients report persistent "brain fog," a subjective yet debilitating cognitive decline. Some researchers now express concern that aggressive cholesterol suppression may be directly linked to or exacerbate neurodegenerative conditions like Alzheimer's and dementia, as we starve the system of the lipid balance necessary for healthy neurological function.

Scientific Findings Versus Industry-Linked Studies: A critical examination of the statin industry reveals a deep chasm between independent scientific findings and studies funded or influenced by pharmaceutical manufacturers.

Independent reviews often find that statins' absolute risk reduction for primary prevention is modest at best, while industry-sponsored trials often minimize adverse event reporting.

When entities whose profitability depends on widespread, lifelong medication adherence bankroll research, the risk-benefit analysis is inevitably skewed; clinical trials designed by drug manufacturers often exclude vulnerable demographics, such as older adults prone to cognitive impairment, yet physicians routinely prescribe these drugs to those exact populations.

The Value of Coenzyme Q10 (CoQ10): One of the most profound biochemical casualties of statin therapy is the depletion of Coenzyme Q10 (CoQ10). Because statins inhibit the mevalonate pathway, the biochemical pathway the body uses to synthesize cholesterol, they also block CoQ10 production, a vital antioxidant and coenzyme required for mitochondrial energy production.

Tissues with the highest energy demands, namely the heart and the skeletal muscles, suffer the most from this depletion. This biochemical starvation explains why statin-induced myalgia and fatigue are so prevalent. Functional medicine practitioners often recommend CoQ10 supplementation to mitigate these exhausting side effects, yet standard cardiological care rarely emphasizes this medication-induced deficiency.

We were all sold a lie that fat makes you fat. We bought into the lie, and so did manufacturers who offered foods and sweets as "low fat" but loaded with sugars and corn syrup, the very culprits that cause free radicals and clog arteries. Let us not forget the American Medical Association, which contributed to the lie and sold us a bill of goods never based on honest scientific trials. If cholesterol is not the primary enemy of the cardiovascular system, what is? The answer isn't natural fats, but the pervasive consumption of refined carbohydrates and processed sugars. When we replace healthy fats with sweets, industrial seed oils, and starches, we create a metabolic environment rife with systemic inflammation. High-sugar diets drive abnormalities including insulin resistance, elevated triglycerides, and the production of oxidized low-density particles that damage the delicate endothelial lining of our arteries. These free radicals and inflammatory markers, triggered by glucose- and fructose-containing sweeteners, contribute directly to arterial plaque formation.

Note: See the complete list of Natural dietary fats found in whole, minimally processed plant and animal sources. Their dominant fatty acid structure typically categorizes them at the end of this blog.

A lab reading of 200 to 300 mg/dL may be healthy and robust for many individuals, provided an inflammatory diet doesn't oxidize those lipids. Conversely, an "artificial" reading achieved through synthetic pharmaceutical suppression may leave the body vulnerable, stripping it of its most potent antioxidant structures and cellular building blocks.

Conclusion: Killing Us Softly?

For millions of patients experiencing chronic fatigue, muscle wasting, and accelerated cognitive decline, the question is far from rhetorical. The multi-billion-dollar Statin Industry relies on a reductionist view of human biology that elevates a vital molecule to public enemy status while ignoring the true drivers of metabolic disease. By shifting our focus from cholesterol fearmongering to reducing systemic inflammation and refined sugars, we can protect cardiovascular health without sacrificing the cognitive vitality our brains need to thrive.

In your blogger’s opinion: One of the most important books you will ever read and read again for your health and the health and safety of those you care about.

Book Review: The Great Cholesterol Myth

Authors: Jonny Bowden, Ph.D., C.N.S., and Stephen Sinatra, M.D., F.A.C.C.

In The Great Cholesterol Myth, Jonny Bowden and Dr. Stephen Sinatra dismantle the conventional medical dogma that dietary and serum cholesterol are the primary drivers of heart disease. Instead, they expose the systemic failures of standard lipid-lowering therapies and challenge the relentless pharmaceutical push behind statins.

The authors argue convincingly that inflammation, oxidative stress, sugar, and insulin resistance are the true culprits behind cardiovascular damage. Backed by clinical insights and biochemical evidence, the book shifts the focus from arbitrary cholesterol targets to a practical, statin-free roadmap focused on genuine metabolic health, proper nutrition, and targeted supplementation like CoQ10—essential reading for anyone questioning the conventional risk-benefit profile of modern cholesterol management.

Important Link: THINCS https://thincs.org/OldSite/index.php

Summary: Critics and modern researchers point to several major methodological and conceptual flaws:

Data Cherry-Picking (Selection Bias)

The 22-Country Problem: At the time of his initial 1953 presentation, data was available for 22 countries, not just 7. When all 22 countries are analyzed (e.g., in famous follow-up analyses by Yerushalmy and Hilleboe), the strong correlation between fat intake and heart disease weakens significantly.

Excluded Outliers: Nations with high fat consumption but low heart disease rates (like France and Switzerland) or low-fat consumption with higher heart disease rates (like Chile) were excluded from the primary focus

About the Author: Kat Kaelin is a retired Kentucky Probation and Parole officer and a Western Kentucky University alumna with a B.S. in Behavioral Science, an MFA in Creative Writing and Publishing, and a background in Research and Statistical Analysis. Her professional background includes service in the U.S. Army Medical Corps, a 10-year enlistment in the U.S. Army Reserve 100th Division, and membership in the National Writers’ Club (1986), now the National Writers’ Association. She brings over 40 years of experience in ghostwriting, research, and statistical analysis to her work as an author and independent blogger. She writes under the professional name Cecilia Payne-Kat Kaelin.

Join me for more true stories taken from life, service, silence, and the human spirit. Thank you for being part of this journey. By sharing our message, we form an alliance of faith, hope, truth, love, and trust, and we flourish and unite nationally and globally.

Blog Disclaimer: I am using my First Amendment rights in the content I share on this blog. The views and opinions expressed in this blog are solely those of the author and do not necessarily represent the views of any organization or institution with which the author may be affiliated. The content provided on this blog is for informational purposes only and should not be considered professional advice. I am not a medical doctor or a scientist; I am a researcher and writer, and I stand by my sources in all investigative reporting. Always consult with a qualified professional for any specific concerns or questions you may have.

Natural dietary fats occur in whole, minimally processed plant and animal sources. Their dominant fatty acid structure typically categorizes them:

Monounsaturated Fats (MUFAs)

Liquid at room temperature and solid when chilled; highly stable and heart-healthy.

Avocados and Avocado Oil: Rich in oleic acid and vitamin E.

Extra Virgin Olive Oil: Packed with polyphenols and oleic acid.

Olives: Whole green and black olives.

Nuts: Macadamias, almonds, hazelnuts, pecans, and pistachios.

Seeds: Pumpkin seeds and sesame seeds (and cold-pressed sesame oil). Flaxseeds, chia seeds, and hemp seeds.

Polyunsaturated Fats (PUFAs)

Essential fats containing omega-3 and omega-6 fatty acids that the body cannot synthesize on its own.

Fatty Fish: Wild salmon, mackerel, sardines, anchovies, herring, and trout (rich in EPA and DHA omega-3s).

Walnuts: Exceptionally high in alpha-linolenic acid (ALA plant omega-3).

Algae & Algal Oil: Plant-based source of direct EPA/DHA omega-3s.

Saturated Fats: Solid at room temperature; stable under high heat. Found in animal products and tropical plants.

Ruminant Animal Fats: Tallow (beef fat), lard (pork fat), and duck fat.

Full-Fat Dairy: Butter, ghee (clarified butter), whole milk, heavy cream, full-fat yogurt, and aged cheeses.

Eggs: Specifically, the yolk, which contains fat-soluble vitamins (A, D, E, K), choline, and healthy fats.

Coconut Products: Coconut oil, coconut butter, coconut milk, and dried coconut (rich in medium-chain triglycerides/MCTs).

Cocoa Butter: The natural fat from cocoa beans used in dark chocolate.

Unprocessed Trans Fats (Ruminant Trans Fats): Unlike artificial, industrially hydrogenated trans fats, these occur naturally in trace amounts in grazing animals and do not carry the same cardiovascular risks.

Vaccenic Acid & Conjugated Linoleic Acid (CLA): Found naturally in grass-fed beef, lamb, and full-fat dairy products from pasture-raised animals.

Sources List

Attardo, S., Musumeci, O., Velardo, D., & Toscano, A. (2022). Statins neuromuscular adverse effects. International Journal of Molecular Sciences, 23(15), 8364.

Bashyal, S. (2024). Conundrum of cholesterol management and health implications of low cholesterol levels: A narrative review. PMC.

DiNicolantonio, J. J., Lucan, S. C., & O'Keefe, J. H. (2016). The evidence for saturated fat and sugar related to coronary heart disease. Progress in Cardiovascular Diseases, 58(4), 464–472.

Jin, U., Park, S. J., & Park, S. M. (2019). Cholesterol metabolism in the brain and its association with Parkinson's disease. Experimental Neurobiology, 28(5), 554–567.

Nago, N., Ishikawa, S., Goto, T., & Kayaba, K. (2011). Low cholesterol is associated with mortality from stroke, heart disease, and cancer: The Jichi Medical School Cohort Study. Journal of Epidemiology, 21(1), 67–74.

Schreurs, B. G. (2010). The effects of cholesterol on learning and memory. Neuroscience & Biobehavioral Reviews, 34(8), 1366–1379.

Thompson, A., & Temple, N. J. (2004). The case for statins: Has it really been made? Journal of the Royal Society of Medicine, 97(10), 461–464.